Journalist harassing people at Town Hall.. I gave him a taste of his own medicine – Video

Posted on by


Journalist harassing people at Town Hall.. I gave him a taste of his own medicine
A Channel 10 journalist was at Town Hall station doing a beat up story on young people evading fares. He was waiting with his camera man for people to be fin...

By: Kieran Adair

See the rest here:

Journalist harassing people at Town Hall.. I gave him a taste of his own medicine - Video

A real face appears between my hands! Spirit?Angel?Medicine man?UFO Friend? – check by yourself! – Video

Posted on by


A real face appears between my hands! Spirit?Angel?Medicine man?UFO Friend? - check by yourself!
This video will help you. How did it came to this video, you can read in the video itself , it is true story., happened while i was practicing to upload my f...

By: healinghandsvideo

Continued here:

A real face appears between my hands! Spirit?Angel?Medicine man?UFO Friend? - check by yourself! - Video

Coalition For The Advancement Of Medical Research Transfers Mission And Assets To Alliance For Regenerative Medicine

Posted on by

WASHINGTON, May 21, 2013 /PRNewswire/ --The Coalition for the Advancement of Medical Research (CAMR) announced today it is transferring its mission and its assets to the Alliance for Regenerative Medicine (ARM).

"Human embryonic stem cell research has grown and evolved to a point where it's time for CAMR to hand off its mission to an organization that can advance policy initiatives to support where the science is now, and where it is headed," said CAMR president Amy Comstock Rick, J.D. "FollowingPresident Obama's March 2009 Executive Orderand subsequentNational Institutes of Health stem cell research guidelines, we've seen the number of human embryonic stem cell research lines on the NIH registry grow from just 21 in 2008 to more than 200 today. The science is strong, and government research funding continues to strengthen the field. The private sector is moving the research forward into patient therapies and treatments, and the Alliance for Regenerative Medicine is absolutely the right organization to shepherd stem cell policy support to the next level."

Founded in 2001 with a mission to protect regenerative medicine and secure federal funding and oversight for human embryonic stem cell research, CAMRhas been the nation's leading bipartisan pro-cures coalition. Comprised of more than 100 nationally recognized patient organizations, universities, scientific societies, and foundations advocating for the advancement of breakthrough research and technologies in the field of medical and health research, CAMR's advocacy and education outreach focused on federal funding and oversight of human embryonic stem cell research and related research fields in which the mission is to develop treatments and cures for individuals with debilitating and life-threatening illnesses and disorders.

"In Washington, D.C., and around the world, researchers and policymakers alike have CAMR leadership and its members to thank for the federal funding guidelines that have helped foster an environment for advances in stem cell research in the past 12 years," said Michael Werner, J.D., executive director of ARM. "We are honored to take on CAMR's mission, meld it with our own, and continue to support the great science that is already contributing to life-giving advances in regenerative medicine."

About the Alliance for Regenerative MedicineThe Alliance for Regenerative Medicine (ARM) is a Washington, DC-based non-profit organization that promotes legislative, regulatory, reimbursement, and financing initiatives necessary to facilitate access to life-giving advances in regenerative medicine. ARM also works to increase public understanding of the field and its potential to transform human healthcare, and provides services to support the growth of its member companies and organizations. Prior to the formation of ARM, there was no advocacy organization operating in Washington, DC to specifically represent the interests of regenerative medicine companies, research institutions, investors, and patient groups supporting more rapid adoption of technologies in our field. To learn more about ARM or to become a member, visit http://www.alliancerm.org.

Media Contacts:

CAMR Sean Tipton CAMR Vice President for Communications stipton@asrm-dc.org 202.421.5112 (mobile)

Carol Blymire CAMR Communications Consultant carol@carolblymire.com 301.332.8090 (mobile)

Alliance for Regenerative MedicineMichael Werner Executive Director, Alliance for Regenerative Medicine 202.419.2515 (office)

Michelle Linn, Linnden Communications michelle@linndencom.com 508.362.3087 (office) 774.696.3803 (mobile)

Read the rest here:

Coalition For The Advancement Of Medical Research Transfers Mission And Assets To Alliance For Regenerative Medicine

Korean Society of Occupational and Environmental Medicine partners with BioMed Central

Posted on by

Public release date: 20-May-2013 [ | E-mail | Share ]

Contact: Rebecca Fairbairn rebecca.fairbairn@biomedcentral.com 44-020-319-22433 BioMed Central

BioMed Central, the open access publisher, is pleased to announce that Annals of Occupational and Environmental Medicine (AOEM), the official academic journal of The Korean Society of Occupational and Environmental Medicine (KSOEM), has moved to BioMed Central's open access publishing platform.

KSOEM was formed in 1988, when the people of Korea began to have concerns regarding health and safety at work. Since then, the organization has collaborated with workers and management to cope with occupational health and safety problems. AOEM is the successor of the Korean Journal of Occupational and Environmental Medicine, which began its first publication in 1989. In its 25th year the journal will be published entirely in English and fully open access, with the aim of gaining a more international scope, this is an exciting step for the society and AOEM.

Editor-in-Chief Sang Baek Ko, Professor of Occupational and Environmental Medicine at Yonsei University Wonju College of Medicine, Korea says: "Annals of Occupational and Environmental Medicine (AOEM), an international journal, intends to address various important topics in occupational and environmental medicine in which many researchers and practitioners over the world including Asian countries would be interested. We will do our best to reshape AOEM into a high-quality top journal in occupational and environmental medicine. In order to meet the goal, we have created the Advisory Editorial Board of the AOEM, consisting of world-class, excellent and experienced professors and researchers in occupational and environmental medicine. We have also implemented a very efficient administrative system in the AOEM for streamlining the whole process from manuscript submission to on-line publication for authors."

AOEM considers original contributions relevant to occupational and environmental medicine and related fields in the form of original articles, review articles, short letters and case reports.

Deborah Kahn, BioMed Central's Publishing Director said "The launch of Annals of Occupational and Environmental Medicine is significant for BioMed Central as it is the first Korean society journal transferred to our open access platform. It is also a milestone for the journal as all of its content will be published in English - the first time in a quarter of a century. BioMed Central and Springer are delighted to have the opportunity to collaborate with KSOEM, and we look forward to helping this journal increase international visibility through open access publishing."

Authors based in the Republic of Korea can apply for a discounted article processing charge (APC) of 800 by mentioning the discount code KORAU at the payment page during submission.

###

For more information please visit the journal website.

The rest is here:

Korean Society of Occupational and Environmental Medicine partners with BioMed Central

Rock Medicine for Deadheads, Punks

Posted on by

Singer Miguel tweeted that he just "got caught up in the moment" when he leapt over the crowd at the Billboard Music Awards and landed on a fan's face Sunday night.

Billboard Music Awards: Stars Dazzle on Red Carpet

The televised accident serves as a reminder that although most concert-goers find themselves in the medical tent because they're dehydrated, more serious injuries can happen.

For instance, concert medical tent volunteer Penny Miller said she watched in horror when a Rolling Stones fan fell from a third-floor stadium balcony, bounced off the second floor balcony and fractured his skull at the Oakland Coliseum in 1981.

"He only lived to tell the tale because he received medical care right on the spot," said Miller, a nurse practitioner in Sacramento, Calif., who has volunteered for Rock Medicine since 1977.

Concert injuries vary depending on the performer, said Gordon Oldham, who directs Rock Medicine, a 40-year-old volunteer organization that provides free "nonjudgmental" medical care at more than 700 concerts and events in Northern California each year.

RELATED: Taylor Swift Dominates Billboard Music Awards With 8 Wins

Ethan Miller/Getty Images

For example, the Grateful Dead fans are going to have different medical needs than the hard-core punk crowd, which forms "mosh" pits at in front of the stage, where people slam-dance into each other, said Oldham.

"There's pit etiquette," Oldham said. "If somebody falls down, they help them back up."

Read more:

Rock Medicine for Deadheads, Punks

Understanding Stresses of Infertility, Tennessee Reproductive Medicine Guarantees IVF Treatments

Posted on by

CHATTANOOGA, Tenn., May 20, 2013 (GLOBE NEWSWIRE) -- Tennessee Reproductive Medicine partners Dr. Rink Murray and Dr. Jessica Scotchie launched the "IVF Guarantee Program" last week as demonstration of their commitment to "do everything possible to minimize the financial and emotional stress of infertility." The IVF guarantee program -- which offers three fresh in vitro fertilization cycles, plus all frozen embryos until live birth occurs or all embryos have been used -- provides patients who do not bring home a baby a 100 percent refund of their money.

Murray and Scotchie, who both completed a fellowship in Reproductive Endocrinology and Infertility (REI) at the University of North Carolina in Chapel Hill, opened doors at TRM five years ago with the vow to remain dedicated to treating each patient as unique with individual needs and reservations about their infertility.

For Murray the commitment is intensely personal. "For 10 years, my wife Kristi and I struggled with infertility that led us across more than 600 miles and to three fertility centers with more cycles of IVF than I can recount. There are many sources of stress when dealing with infertility and TRM was built on the belief that Dr. Scotchie and I are partners in our patients' journey toward fertility."

In the IVF process -- responsible for the creation of more than five million babies worldwide -- specialists combine sperm with an egg (oocyte) or eggs in a laboratory dish. A doctor then transfers the resulting embryo(s) to the uterus to develop naturally.

"TRM has comparatively high IVF success rates for our region," explained Dr. Scotchie who is double board certified in REI and Obstetrics and Gynecology. "Our confidence in TRM's cutting-edge technology and proven techniques allows us to offer this program that we hope will provide peace of mind and decreased stress during the treatment cycles."

The cost of the IVF guarantee program is $24,000 or $25,800 if ICSI is required.

Tennessee Reproductive Medicine (TRM) is a full-service reproductive endocrinology and fertility clinic located in Chattanooga, Tennessee with satellite monitoring centers in Knoxville, Tenn., Cookeville, Tenn. and Rome, Ga. TRM's goal is to provide the most advanced medical and surgical care to patients suffering from infertility, recurrent pregnancy loss, endometriosis, reproductive endocrine disorders (such as polycystic ovary syndrome and premature ovarian failure), abnormal menses and menopause.

For real-time updates please visit Facebook.com/TennesseeReproductiveMedicine or Twitter.com/FertilityAlert.

More here:

Understanding Stresses of Infertility, Tennessee Reproductive Medicine Guarantees IVF Treatments

Celerion Appoints Dr. Bruce Morimoto as Executive Director, Applied Translational Medicine

Posted on by

LINCOLN, Neb.--(BUSINESS WIRE)--

Celerion is pleased to announce the appointment of Dr. Bruce Morimoto as Executive Director of Applied Translational Medicine. Dr. Morimoto will have responsibility for developing and implementing strategies for patient populations in early clinical research and clinical pharmacology studies. Dr. Morimoto will also assume leadership for the External Studies Management and Clinical Monitoring Services teams.

The appointment of Dr. Morimoto reinforces Celerions focus on delivering Applied Translational Medicine.Celerion is focused on applying our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.

Dr. Morimoto comes to Celerion with over 20 years of experience in the pharmaceutical and biotechnology industries as well as in contract research organizations (CRO). Prior to joining Celerion, he was Vice President of Drug Development at Allon Therapeutics, where his focus was to manage their neurodegeneration and dementia therapeutic programs including preclinical, manufacturing and clinical development. Dr. Morimoto also held positions at MDS Pharma Services, a full service CRO; Neuromed Technologies, a biotech company developing novel pain therapeutics; Phoenix International Life Sciences, a global CRO; and Amur Pharmaceuticals, a biopharmaceutical company focused on diabetes and drug delivery research.

Dr. Morimotos hands-on drug development experience that includes program, project and portfolio management, combined with an understanding of the CRO industry, provides him with invaluable insight into how best to tackle the inclusion of patients in both clinical pharmacology as well as Phase IIa Proof-of-Concept studies.

We are very pleased to have Bruce join the Drug Development Services team at Celerion, said Susan Thornton Ph.D, President and CEO of Celerion. His in-depth knowledge of drug development as well as focus on Applied Translational Medicine from both the client and CRO perspective will be a great asset to our organization.

Dr. Morimoto earned his doctorate in biochemistry from the University of California, Los Angeles (UCLA), completed post doctorate research at University of California, Berkeley, and was also on the faculty in the Chemistry department at Purdue University.

About Celerion Celerion, a leader in early clinical research, delivers Applied Translational Medicine.Celerion applies our expertise and experience to translating information gained in research discoveries, to knowledge of drug action and effect in humans to support early drug development decisions and the clinical pharmacology labeling of new medicines.

With over 40 years of experience and 750 global clinic beds (including 24 in-hospital), Celerion conducts and analyzes First-in-Human, clinical proof-of-concept, cardiac safety (TQT, robust QT), ADME and NDA-enabling clinical pharmacology studies. Celerion provides expertise on modeling and simulation, study design, medical writing (protocols and reports), clinical data sciences, biostatistics, and PK/PD analysis as well as small and large molecule bioanalytical assays through clinical drug development. Regulatory, drug development and program management complement Celerions service offerings. For more information please visit http://www.celerion.com.

Continued here:

Celerion Appoints Dr. Bruce Morimoto as Executive Director, Applied Translational Medicine